Primary type II alveolar epithelial cells present microbial antigens to antigen-specific CD4+ T cells |
| |
Authors: | Debbabi Hajer Ghosh Shamik Kamath Arati B Alt Jennifer Demello Daphne E Dunsmore Sarah Behar Samuel M |
| |
Institution: | Division of Rheumatology, Brigham and Women's Hospital, Smith Bldg., Rm. 516, 1 Jimmy Fund Way, Boston, MA 02115, USA. |
| |
Abstract: | Type II alveolar epithelial cells (AEC) can produce various antimicrobial and proinflammatory effector molecules. This, together with their abundance and strategic location, suggests a role in host defense against pulmonary pathogens. We report that murine type II AEC, like their human counterparts, express class II major histocompatibility complex (MHC). Using a murine model of pulmonary tuberculosis, we find that type II AEC become activated and have increased cell surface expression of class II MHC, CD54, and CD95 following infection. Type II AEC use the class II MHC pathway to process and present mycobacterial antigens to immune CD4+ T cells isolated from mice infected with Mycobacterium tuberculosis. Therefore, not only can type II AEC contribute to the pulmonary immunity by secreting chemokines that recruit inflammatory cells to the lung, but they can also serve as antigen-presenting cells. Although type II AEC are unlikely to prime na?ve T cells, their ability to present antigens to T cells demonstrates that they can participate in the effector phase of the immune response. This represents a novel role for type II AEC in the immunological response to pulmonary pathogens. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|